Log in  First Connection?

Abdominal ImagingArchives

Preoperative prediction of microvascular invasion and relapse-free survival in hepatocellular Carcinoma ≥3 cm using CT radiomics: Development and external validation

 Published on 08/05/2025 |  Original article (Full-text)  | Zhong Hua et al. | BMC Medical Imaging 2025; 25(1): 142

Hepatocellular carcinoma (HCC) is one of the leading cancers with rising prevalence, high mortality and poor clinical outcome all over the world [1, 2]. Microvascular invasion (MVI), which refers to the presence of clusters of cancer cells in blood vessels with endothelial cell linings, commonly most...

Histologic Diagnosis of Pancreatic Cystic Lesions with Endoscopic Ultrasound Fine Needle Biopsy and Impact on Management Decisions

 Published on 01/05/2025 |  Original article (Full-text)  | Ankit Mishra et al. | Digestive Diseases and Sciences 2025; aop: 10.1007/s10620-025-09056-1

It is estimated that 16% of the general population have pancreatic cystic lesions (PCLs) [1]. The majority of PCLs represent branch-duct intraductal papillary mucinous neoplasms (IPMNs), which are precursors of pancreatic cancer [2]. Surgical resection is often indicated for IPMNs with high-grade dysplasia/adenocarcinoma...

Radiomics analysis of dual-layer detector spectral CT-derived iodine maps for predicting Ki-67 PI in pancreatic ductal adenocarcinoma

 Published on 24/04/2025 |  Original article (Full-text)  | Zeng Dan et al. | BMC Medical Imaging 2025; 25(1): 124

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant disease with a 5-year survival rate of <12%. It is projected to become the second-leading cause of cancer-related deaths by 2030 [1, 2]. Ki-67 is a marker to distinguish between proliferating and non-proliferating cells [3]. A high Ki-67...

Dosimetric investigation of multi-parametric 4D-MRI for radiotherapy in liver cancer

 Published on 17/04/2025 |  Original article (Full-text)  | Li Sha et al. | Radiation Oncology 2025; 20(1): 51

Currently, liver cancer ranks as the fourth leading cause of cancer-related deaths globally [1, 2–3]. The incidence and mortality rates of liver cancer have shown a concerning growth, with a 27% increase in incident cases and a 25% rise in mortality rates between 2010 and 2019 [4]. Traditionally,...

Predicting treatment response and prognosis of immune checkpoint inhibitors-based combination therapy in advanced hepatocellular carcinoma using a longitudinal CT-based radiomics model: a multicenter study

 Published on 10/04/2025 |  Original article (Full-text)  | Xu Jun et al. | BMC Cancer 2025; 25(1): 602

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and ranks third in terms of cancer-related deaths [1]. Immune checkpoint inhibitors(ICIs) targeting programmed death ligand 1 (PD-(L)1) inhibitors, in conjunction with tyrosine kinase inhibitors (TKIs) or vascular endothelial growth...